Cargando…
Chronological Analysis of First-in-Class Drugs Approved from 2011 to 2022: Their Technological Trend and Origin
The discovery and development of first-in-class (FIC) drugs are becoming increasingly important due to increasing reimbursement pressure and personalized medication. To investigate the technological trends and origin of FIC drugs, the FIC drugs approved in the U.S. from January 2011 to December 2022...
Autor principal: | Okuyama, Ryo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386398/ https://www.ncbi.nlm.nih.gov/pubmed/37513981 http://dx.doi.org/10.3390/pharmaceutics15071794 |
Ejemplares similares
-
Trends and Characteristics of New Drug Approvals in China, 2011–2021
por: Su, Ling, et al.
Publicado: (2022) -
FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022
por: Rizzo, Carla, et al.
Publicado: (2023) -
The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules
por: de la Torre, Beatriz G., et al.
Publicado: (2023) -
Trends in US Adult Smoking Prevalence, 2011 to 2022
por: Meza, Rafael, et al.
Publicado: (2023) -
Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016–2022)
por: Shabir, Ghulam, et al.
Publicado: (2023)